Core Viewpoint - A securities class action lawsuit has been filed against Apple Inc. for allegedly making false and misleading statements regarding the integration of advanced AI-based Siri features into its devices, which may impact iPhone 16 sales and overall business prospects [2][4]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Northern District of California on behalf of investors who purchased Apple securities between June 10, 2024, and June 9, 2025 [1]. - The lead plaintiff deadline for the lawsuit is August 19, 2025 [1][3]. Group 2: Allegations Against Apple - The complaint alleges that Apple misstated the time required to integrate advanced AI-based Siri features, making it unlikely these features would be available for the iPhone 16 [2]. - The absence of these advanced features is claimed to negatively affect iPhone 16 sales, leading to an overstatement of Apple's business and financial prospects [2]. Group 3: Lead Plaintiff Process - Investors may seek to be appointed as a lead plaintiff representative of the class by the deadline or may choose to remain absent [3]. - The lead plaintiff will act on behalf of all class members and select counsel to represent the class [3]. Group 4: Firm Background - Kessler Topaz Meltzer & Check, LLP has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [4].

Core Viewpoint - Johnson Fistel, PLLP is investigating RXO, Inc. for potential violations of federal securities laws related to misrepresentation or failure to disclose material information to investors [1] Group 1: Investigation Details - The investigation focuses on whether RXO, Inc. or its officers and directors misrepresented or failed to disclose important information to investors [1] - Individuals who purchased RXO securities and experienced losses are encouraged to join the investigation [2] Group 2: Whistleblower Information - Individuals with nonpublic information about RXO are advised to consider assisting the investigation or utilizing the SEC Whistleblower program, which may offer rewards up to 30% of successful recoveries [3] Group 3: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights, with offices across multiple states [4] - The firm has been ranked in the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services in 2024, recovering approximately $90,725,000 for clients [5]

Core Viewpoint - DJS Law Group is investigating claims against RxSight, Inc. for potential violations of securities laws related to misleading statements and undisclosed information impacting investors [1][2]. Investigation Details - The investigation centers on RxSight's financial performance, particularly the decline in sales of Light Delivery Devices (LDD) and total revenue [2]. - RxSight reported a significant drop in key metrics and lowered its full-year financial guidance, attributing the changes to "adoption challenges" leading to an "LDD stall" [2]. - Following the financial report, RxSight's shares plummeted by nearly 38% on the announcement day [2].

Core Viewpoint - A class action lawsuit has been filed against Replimune Group, Inc. for alleged violations of securities laws, specifically related to misleading statements about the company's clinical trial results [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to investors who purchased Replimune's securities between November 22, 2024, and July 21, 2025 [2]. - The Schall Law Firm is representing the investors and encourages those who suffered losses to participate in the lawsuit [5]. Group 2: Allegations Against the Company - The complaint alleges that Replimune made false and misleading statements regarding the IGNYTE trial for RP1 (vusolimogene oderparepvec) [4]. - It is claimed that the company overstated the prospects of the trial and was aware of material issues that could lead to the FDA deeming the trial inadequate [4]. - As a result of these misleading statements, investors experienced financial damages when the truth about the company's situation was revealed [4].

Core Viewpoint - A class action lawsuit has been filed against Luminar Technologies, Inc. for alleged securities fraud, claiming that the company failed to disclose material adverse facts regarding its operations and compliance, particularly concerning CEO Austin Russell's undisclosed conduct [1][5]. Company Overview - Luminar Technologies specializes in advanced LiDAR hardware and software solutions for vehicles [4]. - The company issued its quarterly business update and financial results for Q4 2024 and the full year 2024 on March 20, 2025, and reiterated its guidance for the full year 2025 in its Q1 2025 update on May 14, 2025 [4]. Legal Proceedings - The class action lawsuit, Yskollari v. Luminar Technologies, Inc., was initiated in the United States District Court for the Middle District of Florida [1]. - Investors who purchased Luminar securities between March 20, 2025, and May 14, 2025, are eligible to participate in the lawsuit [1][7]. Allegations - The complaint alleges that Luminar's executives made false or misleading statements and failed to disclose significant risks related to CEO Austin Russell's conduct, which could jeopardize his position and the company's business [5]. - The lawsuit claims that the lack of transparency regarding Russell's situation undermined the company's financial guidance and misled investors [5]. Market Reaction - Following the announcement of Russell's resignation on May 14, 2025, Luminar's stock price dropped by $0.80, or 16.80%, closing at $3.96 per share on May 15, 2025 [6].

LOS ANGELES, July 24, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR BIOHAVEN INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOV ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit. Why is BellRing being Investigated? BellRing operates in the convenient nutrition category. The Company’s pr ...

PHILADELPHIA, July 23, 2025 /PRNewswire/ -- Berger Montague, with offices in Canada and throughout the United States, is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ascot Resources Ltd. ("Ascot" or the "Company") (AOT.TO; AOTVF; BHQ.F; BHQ.DU; BHQ.MU).CLICK HERE TO LEARN MORE ABOUT THE INVESTIGATIONAscot, headquartered in Vancouver, BC, engages in the exploration and development of mineral properties in the United States and Canada. Its main asset ...

Investors can contact the law firm at no cost to learn more about recovering their losses​ LOS ANGELES, July 23, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. RxSight investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Les ...

Core Viewpoint - Barnes & Noble Education, Inc. is under investigation for potential securities fraud and unlawful business practices, which has led to a significant drop in its stock price following the announcement of a delay in its annual report due to accounting issues [1][3][4]. Group 1: Investigation Details - Pomerantz LLP is investigating claims on behalf of investors regarding potential securities fraud by Barnes & Noble and its officers or directors [1]. - The investigation is focused on how the costs of digital sales were recorded, with early findings suggesting that accounts receivable may have been overstated by up to $23 million [3]. Group 2: Financial Impact - Following the announcement of the investigation and the delay in the annual report, Barnes & Noble's stock price fell by $2.36 per share, representing a 21.02% decrease, closing at $8.87 per share on July 21, 2025 [4]. Group 3: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering multimillion-dollar damages for victims of securities fraud and corporate misconduct [5].